Elucidating the precise pharmacological mechanism of action (MOA) of Normally occurring compounds is often tough. While Tarselli et al. (60) formulated the initial de novo synthetic pathway to conolidine and showcased this Normally transpiring compound efficiently suppresses responses to the two chemically induced and inflammation-derived pain, the… Read More